Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging

被引:0
|
作者
Hutchinson, M
Raff, U
机构
[1] NYU, Sch Med, Dept Neurol, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Radiol, New York, NY 10016 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: The possibility of using MR imaging as a sensitive marker of the structural changes in Parkinson's disease has been a long-sought goal. We describe a new method for imaging and quantifying the morphologic changes of the substantia nigra in Parkinson's disease and compare radiologic findings with clinical evaluation. METHODS: Using a combination of two MR imaging inversion-recovery pulse sequences, the substantia nigra was imaged in six patients with Parkinson's disease and six age-related control participants. A radiologic index was defined and used to quantify the signal changes that were observed in the patients. The radiologic index was compared with clinical scores obtained from the Unified Parkinson's Disease Rating Scale. RESULTS: The images showed loss of signal in a lateral-to-medial gradient in cases of Parkinson's disease, corresponding to the known neuropathologic pattern of degeneration. The radiologic index was highly correlated with the Unified Parkinson's Disease Rating Scale score, and there was no overlap in radiologic indices between the patient and the control groups (P < .00005), CONCLUSION: This study suggests that MR imaging is sensitive to structural changes in even the earliest cases of Parkinson's disease, thereby indicating the potential for detecting presymptomatic disease. Furthermore, a radiologic measure has been defined that correlates with the conventional clinical measure of disease severity. Therefore, MR imaging could prove to be a sensitive biological marker for objective staging of the disease.
引用
收藏
页码:697 / 701
页数:5
相关论文
共 50 条
  • [41] Multimodal Imaging of Substantia Nigra in Parkinson's Disease with Levodopa-Induced Dyskinesia
    Su, Dongning
    Gan, Yawen
    Zhang, Zhe
    Cui, Yusha
    Zhang, Zhijin
    Liu, Zhu
    Wang, Zhan
    Zhou, Junhong
    Sossi, Vesna
    Stoessl, A. Jon
    Wu, Tao
    Jing, Jing
    Feng, Tao
    MOVEMENT DISORDERS, 2023, 38 (04) : 616 - 625
  • [42] Quantitative Susceptibility Mapping and Free Water Imaging of Substantia Nigra in Parkinson's Disease
    Zhang, Dongling
    Yao, Junye
    Sun, Junyan
    Tong, Qiqi
    Zhu, Silei
    Wang, Junling
    Chen, Lili
    Ma, Jinghong
    He, Hongjian
    Wu, Tao
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (08) : 2469 - 2478
  • [43] Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease
    Sasaki, Makoto
    Shibata, Eri
    Tohyama, Koujiro
    Takahashi, Junko
    Otsuka, Kotaro
    Tsuchiya, Kuniaki
    Takahashi, Satoshi
    Ehara, Shigeru
    Terayama, Yasuo
    Sakai, Akio
    NEUROREPORT, 2006, 17 (11) : 1215 - 1218
  • [44] Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease
    Prakash, Bhaskaran David
    Sitoh, Yih-Yian
    Tan, Louis C. S.
    Au, Wing Lok
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (09) : 1029 - 1033
  • [46] Longitudinal changes in free-water within the substantia nigra of Parkinson's disease
    Ofori, Edward
    Pasternak, Ofer
    Planetta, Peggy J.
    Li, Hong
    Burciu, Roxana G.
    Snyder, Amy F.
    Lai, Song
    Okun, Michael S.
    Vaillancourt, David E.
    BRAIN, 2015, 138 : 2322 - 2331
  • [47] Neurosteroid Biosynthetic Pathway Changes in Substantia Nigra and Caudate Nucleus in Parkinson's Disease
    Luchetti, Sabina
    Bossers, Koen
    Frajese, Giovanni Vanni
    Swaab, Dick F.
    BRAIN PATHOLOGY, 2010, 20 (05) : 945 - 951
  • [48] Spatial variations and precise location of substantia nigra hyperechogenicity in Parkinson’s disease using TCS-MR fusion imaging
    Chao Hou
    Wei Zhang
    Hong-Bing Li
    Shuo Li
    Fang Nie
    Xue-Mei Wang
    Wen He
    npj Parkinson's Disease, 11 (1)
  • [49] Different Clinical Implications of Substantia Nigra R2*and Diffusion Tenser Imaging Changes in Parkinson's Disease
    Du, Guangwei
    Lewis, Mechelle
    Sen, Suman
    Shaffer, Michele
    Styner, Martin
    Wang, Jianli
    Yang, Qing
    Huang, Xuemei
    NEUROLOGY, 2012, 78
  • [50] MICROGLIAL ACTIVATION BEYOND THE SUBSTANTIA NIGRA IN PARKINSON'S DISEASE
    Doorn, K.
    Lucassen, P. J.
    Bol, J. G. J.
    Drukarch, B.
    van de Berg, W. D. J.
    van Dam, A-M.
    GLIA, 2013, 61 : S166 - S167